VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $297,993,682 | -6.7% | 11,073,715 | +4.3% | 0.03% | -3.2% |
Q2 2023 | $319,558,303 | -6.4% | 10,613,028 | +0.5% | 0.03% | -16.2% |
Q1 2023 | $341,481,861 | +14.7% | 10,555,852 | +1.6% | 0.04% | +8.8% |
Q4 2022 | $297,785,053 | -0.5% | 10,390,267 | -16.3% | 0.03% | -17.1% |
Q3 2022 | $299,431,000 | +11.1% | 12,414,191 | +26.2% | 0.04% | +17.1% |
Q2 2022 | $269,442,000 | -25.7% | 9,840,805 | +4.1% | 0.04% | -28.6% |
Q1 2022 | $362,645,000 | +29.6% | 9,456,194 | +8.2% | 0.05% | +40.0% |
Q4 2021 | $279,852,000 | -13.3% | 8,737,175 | -20.2% | 0.04% | -18.6% |
Q3 2021 | $322,686,000 | -10.7% | 10,949,644 | +3.0% | 0.04% | -10.4% |
Q2 2021 | $361,235,000 | +10.3% | 10,630,809 | +5.5% | 0.05% | 0.0% |
Q1 2021 | $327,608,000 | -8.7% | 10,080,251 | +1.2% | 0.05% | -12.7% |
Q4 2020 | $358,654,000 | -19.4% | 9,957,079 | -12.4% | 0.06% | -36.0% |
Q3 2020 | $445,067,000 | +22.3% | 11,365,357 | +14.6% | 0.09% | +6.2% |
Q2 2020 | $363,781,000 | +35.5% | 9,917,660 | -14.9% | 0.08% | +11.0% |
Q1 2020 | $268,490,000 | +2.1% | 11,653,212 | +29.8% | 0.07% | +19.7% |
Q4 2019 | $262,961,000 | +2.1% | 8,980,900 | -6.9% | 0.06% | -10.3% |
Q3 2019 | $257,619,000 | +31.8% | 9,644,973 | +26.1% | 0.07% | +30.8% |
Q2 2019 | $195,480,000 | +10.2% | 7,647,844 | -3.3% | 0.05% | +4.0% |
Q1 2019 | $177,351,000 | -29.6% | 7,910,361 | -33.8% | 0.05% | -33.3% |
Q4 2018 | $251,864,000 | -44.7% | 11,942,331 | -51.4% | 0.08% | -34.2% |
Q3 2018 | $455,227,000 | +47.5% | 24,580,270 | +77.7% | 0.11% | +37.3% |
Q2 2018 | $308,600,000 | +2.9% | 13,832,316 | +1.4% | 0.08% | 0.0% |
Q1 2018 | $299,889,000 | +4.6% | 13,643,795 | +10.6% | 0.08% | +6.4% |
Q4 2017 | $286,795,000 | -25.6% | 12,340,607 | -26.5% | 0.08% | -32.8% |
Q3 2017 | $385,645,000 | -27.0% | 16,796,440 | -29.8% | 0.12% | -27.5% |
Q2 2017 | $528,210,000 | -43.9% | 23,922,549 | -42.0% | 0.16% | +11.1% |
Q1 2017 | $940,744,000 | +104.7% | 41,242,566 | +87.8% | 0.14% | +92.0% |
Q4 2016 | $459,540,000 | +66.4% | 21,966,542 | +110.3% | 0.08% | -20.2% |
Q3 2016 | $276,124,000 | -64.3% | 10,447,354 | -62.6% | 0.09% | -66.3% |
Q2 2016 | $773,744,000 | – | 27,922,902 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |